Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Experience With Deucravacitinib for the Treatment of Idiopathic Inflammatory Myopathies -- a Prospective Observational Study

NCT07564271 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07564271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Experience With Deucravacitinib for the Treatment of Idiopathic Inflammatory Myopathies -- a Prospective Observational Study
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Withdrawn
Start date
October 5, 2025
Completion date
October 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic inflammatory myopathies (iims)